MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

462.99 +3.78 (+0.82%)
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 310,232
Open 459.39
Bid (Size) 462.00 (40)
Ask (Size) 465.00 (80)
Prev. Close 459.21
Today's Range 459.08 - 464.44
52wk Range 362.50 - 519.68
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The $1.7 Billion Pivot: Agios Pharmaceuticals (AGIO) and the New Frontier of Oral Thalassemia Therapy
On December 23, 2025, the biotechnology landscape shifted for thousands of patients living with chronic anemia. The U.S. Food and Drug Administration (FDA) granted approval to AQVESME (mitapivat),... 
Via PredictStreet
Topics Economy
News headline image
Is CRISPR Therapeutics Stock Yesterday's News? ↗
The biotech sells blood disorders treatment, Casgevy. 
Via The Motley Fool

Performance

YTD
+14.1%
+14.1%
1 Month
+7.7%
+7.7%
3 Month
+21.2%
+21.2%
6 Month
+4.4%
+4.4%
1 Year
+12.7%
+12.7%

More News

Read More
News headline image
Vertex to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Moderna (MRNA): The “Act 2” of an mRNA Pioneer – A 2025 Deep Dive
Via PredictStreet
Topics Earnings Initial Public Offering Intellectual Property
News headline image
Vertex Pharmaceuticals Inc (NASDAQ:VRTX): A GARP Case Study in Affordable Growth ↗
Via Chartmill
News headline image
2 Cash-Producing Stocks to Consider Right Now and 1 We Find Risky
Via StockStory
News headline image
Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026? ↗
Via The Motley Fool
News headline image
2 Reasons to Watch VRTX and 1 to Stay Cautious
Via StockStory
Topics Stocks
News headline image
From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
From USA News Group
Via GlobeNewswire
News headline image
12 Days of Investing: My Top 12 Stocks to Buy Before 2026 ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Vertex Pharmaceuticals (NASDAQ:VRTX) Combines Strong Growth with Technical Breakout Potential ↗
Via Chartmill
News headline image
2 Healthcare Stocks to Buy Ahead of the New Year ↗
Via The Motley Fool
News headline image
1 Large-Cap Stock to Consider Right Now and 2 Facing Challenges
Via StockStory
News headline image
Beyond AI: How Non-AI Tech Innovations are Fueling a New Era of Stock Market Growth
Via MarketMinute
Topics Artificial Intelligence Economy Emissions
News headline image
Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals? ↗
Via The Motley Fool
News headline image
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
1 Reason I'll Never Sell Vertex Pharmaceuticals Stock ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Which S&P500 stocks are moving on Wednesday? ↗
Via Chartmill
News headline image
Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today
Via StockStory
Topics Artificial Intelligence Economy
News headline image
What's going on in today's session: S&P500 movers ↗
Via Chartmill
News headline image
2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
3 Top Stocks to Buy in December ↗
Via The Motley Fool
News headline image
Meet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50% ↗
Via The Motley Fool
Topics ETFs
News headline image
Vertex (VRTX) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Where Will Vertex Pharmaceuticals Be in 5 Years ↗
Via The Motley Fool

Frequently Asked Questions

Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 462.99
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 12/24/25 01:00 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 120.11B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 120B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story